Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: Similarities and differences

Fluids and Barriers of the CNS

Volumn 8, Issue 1, 2011, Pages

  Redzic, Zoran ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; AMINO ACID; CARRIER PROTEIN; GLUCOSE; NEUROTRANSMITTER; XENOBIOTIC AGENT;

ARACHNOID; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN CAPILLARY; CHOROID PLEXUS; ENDOTHELIUM CELL; EPITHELIUM CELL; EXTRACELLULAR FLUID; HOMEOSTASIS; HUMAN; INTERSTITIAL FLUID; MOLECULAR BIOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; TIGHT JUNCTION;

EID: 80051728609     PISSN: None     EISSN: 20458118     Source Type: Journal    
DOI: 10.1186/2045-8118-8-3     Document Type: Review

References (257)

1. Crone C, Christensen O. Electrical resistance of a capillary endothelium. J Gen Physiol 1981, 77:349-371. 10.1085/jgp.77.4.349, 2215420, 7241087.
2. Bradbury MW. The Concept of a Blood-Brain Barrier 1979, Chichester: Wiley.
3. Begley DJ, Brightman MW. Structural and functional aspects of the blood-brain barrier. Prog Drug Res 2003, 61:39-78.
4. Kuschinsky W, Paulson OB. Capillary circulation in the brain. Cerebrovasc Brain Metab Rev 1992, 4:261-286.
5. Del Bigio MR. The ependyma: a protective barrier between brain and cerebrospinal fluid. Glia 1995, 14:1-13. 10.1002/glia.440140102, 7615341.
6. Saito Y, Wright EM. Regulation of bicarbonate transport across the brush border membrane of the bull-frog choroid plexus. J Physiol 1984, 350:327-342. 1199272, 6611401.
7. Welch K, Araki H. Features of the choroid plexus of the cat, studied in vitro. Fluid Environment of the Brain 1975, 157-165. New York: Academic Press, Cserr HF, Fenstermacher JD, Fencl V.
8. Scott DE, Kozlowski GP, Sheridan MN. Scanning electron microscopy in the ultrastructural analysis of the mammalian cerebral ventricular system. Int Rev Cytol 1974, 37:349-388. full_text, 4209574.
9. Keep RF, Jones HC. A morphometric study on the development of the lateral ventricle choroid plexus, choroid plexus capillaries and ventricular ependyma in the rat. Dev Brain Res 1990, 56:47-53.
10. Hawkins BT, Davis TP. The blood-brain barrier neurovascular unit in health and disease. Pharmacol Rev 2005, 57:173-185. 10.1124/pr.57.2.4, 15914466.
11. Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Ruco L, Villa A, Simmons D, Dejana E. Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 1998, 142:117-127. 10.1083/jcb.142.1.117, 2133024, 9660867.
12. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Prog Biophys Mol Biol 2003, 81:1-44. 10.1016/S0079-6107(02)00037-8, 12475568.
13. Li Y, Fanning AS, Anderson JM, Lavie A. Structure of the conserved cytoplasmic C-terminal domain of occludin: identification of the ZO-1 binding surface. J Mol Biol 2005, 352:151-164. 10.1016/j.jmb.2005.07.017, 16081103.
14. Feldman GJ, Mullin JM, Ryan MP. Occludin: structure, function and regulation. Adv Drug Deliv Rev 2005, 57:883-917. 10.1016/j.addr.2005.01.009, 15820558.
15. Andreeva AY, Piontek J, Blasig IE, Utepbergenov DI. Assembly of tight junction is regulated by the antagonism of conventional and novel protein kinase C isoforms. Int J Biochem Cell Biol 2006, 38:222-233.
16. Saitou M, Furuse M, Sasaki H, Schulzke D, Fromm M, Takano H, Noda T, Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 2000, 11:4131-4142. 15062, 11102513.
17. Saitou M, Fujimoto K, Doi Y, Itoh M, Fujimoto T, Furuse M, Takano H, Noda T, Tsukita S. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol 1998, 141:397-408. 10.1083/jcb.141.2.397, 2148457, 9548718.
18. Bamforth SD, Kniesel U, Wolburg H, Engelhardt B, Risau W. A dominant mutant of occludin disrupts tight junction structure and function. J Cell Sci 1999, 112:1879-1888.
19. Terai T, Nishimura N, Kanda I, Yasui N, Sasaki T. JRAB/MICAL-L2 is a junctional Rab13-binding protein mediating the endocytic recycling of occludin. Mol Biol Cell 2006, 17:2465-2475. 10.1091/mbc.E05-09-0826, 1446078, 16525024.
20. Romanitan MO, Popescu BO, Winblad B, Bajenaru OA, Bogdanovic N. Occludin is overexpressed in Alzheimer's disease and vascular dementia. J Cell Mol Med 2007, 11:569-579. 10.1111/j.1582-4934.2007.00047.x, 17635647.
21. Heiskala M, Peterson PA, Yang Y. The roles of claudin superfamily proteins in paracellular transport. Traffic 2001, 2:93-98. 10.1034/j.1600-0854.2001.020203.x, 11247307.
22. Piontek J, Winkler L, Wolburg H, Muller SL, Zuleger N, Piehl C, Wiesner B, Krause G, Blasig IE. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J 2008, 22:146-158. 10.1096/fj.07-8319com, 17761522.
23. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003, 161:653-660. 10.1083/jcb.200302070, 2172943, 12743111.
24. Ruffer C, Gerke V. The C-terminal cytoplasmic tail of claudins 1 and 5 but not its PDZ-binding motif is required for apical localization at epithelial and endothelial tight junctions. Eur J Cell Biol 2004, 83:135-144. 10.1078/0171-9335-00366, 15260435.
25. Matter K, Balda MS. Holey barrier: claudins and the regulation of brain endothelial permeability. J Cell Biol 2003, 161:459-460. 10.1083/jcb.200304039, 2172932, 12743096.
26. Van Itallie CM, Anderson JM. The role of claudins in determining paracellular charge selectivity. Proc Am Thorac Soc 2004, 1:38-41. 10.1513/pats.2306013, 16113410.
27. Wolburg H, Wolburg-Buchholz K, Liebner S, Engelhardt B. Claudin- 1, claudin-2 and claudin-11 are present in tight junctions of choroid plexus epithelium of the mouse. Neurosci Lett 2001, 307:77-80. 10.1016/S0304-3940(01)01927-9, 11427304.
28. Wolburg H, Noell S, Wolburg-Buchholz K, Mack AF, Fallier-Becker P. Agrin, aquaporin-4, and astrocyte polarity as an important feature of the blood-brain barrier. Neuroscientist 2009, 15:180-193. 10.1177/1073858408329509, 19307424.
29. Goldmann EE. Vitalfarbung am Zentralnervensystem. Abh preuss Akad Wiss Phys-Math 1913, 1:1-60.
30. Wolburg H, Paulus W. Choroid plexus: biology and pathology. Acta Neuropathol 2010, 119:75-88. 10.1007/s00401-009-0627-8, 20033190.
31. Sandri C, Akert K, Bennett MV. Junctional complexes and variations in gap junctions between spinal cord ependymal cells of a teleost Sternarchus albifrons (Gymnotoidei). Brain Res 1978, 143:27-41. 10.1016/0006-8993(78)90750-3, 630402.
32. Zamora AJ, Thiesson D. Tight junctions in the ependyma of the spinal cord of the urodele Pleurodeles waltlii. Anat Embryol 1980, 160:263-274. 10.1007/BF00305107, 7457921.
33. Mollgard K, Balslev Y, Lauritzen B, Saunders NR. Cell junctions and membrane specializations in the ventricular zone (germinal matrix) of the developing sheep brain: a CSF-brain barrier. J Neurocytol 1987, 16:433-444. 10.1007/BF01668498, 3681347.
34. Bazzoni G, Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 2004, 84:869-901. 10.1152/physrev.00035.2003, 15269339.
35. Bazzoni G, Martinez-Estrada OM, Mueller F, Nelboeck P, Schmid G, Bartfai T, Dejana E, Brockhaus M. Homophilic interaction of junctional adhesion molecule. J Biol Chem 2000, 275:30970-30976. 10.1074/jbc.M003946200, 10913139.
36. Itoh M, Sasaki H, Furuse M, Ozaki H, Kita T, Tsukita S. Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol 2001, 154:491-497. 10.1083/jcb.200103047, 2196413, 11489913.
37. Suzuki A, Ishiyama C, Hashiba K, Shimizu M, Ebnet K, Ohno S. aPKC kinase activity is required for the asymmetric differentiation of the premature junctional complex during epithelial cell polarization. J Cell Sci 2002, 115:3565-3573. 10.1242/jcs.00032, 12186943.
38. Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 2001, 24:719-725. 10.1016/S0166-2236(00)02004-X, 11718877.
39. Enerson BE, Drewes LR. The rat blood-brain barrier transcriptome. J Cereb Blood Flow Metab 2006, 26:959-973. 10.1038/sj.jcbfm.9600249, 16306934.
40. Koto T, Takubo K, Ishida S, Shinoda H, Inoue M, Tsubota K, Okada Y, Ikeda E. Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol 2007, 170:1389-1397. 10.2353/ajpath.2007.060693, 1829471, 17392177.
41. Kago T, Takagi N, Date I, Takenaga Y, Takagi K, Takeo S. Cerebral ischemia enhances tyrosine phosphorylation of occludin in brain capillaries. Biochem Biophys Res Commun 2006, 339:1197-1203. 10.1016/j.bbrc.2005.11.133, 16338221.
42. Mark KS, Davis TP. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol 2002, 282:H1485 H1494.
43. Fischer S, Wiesnet M, Marti HH, Renz D, Schaper W 2004. Simultaneous activation of several second messengers in hypoxia-induced hyperpermeability of brain derived endothelial cells. J Cell Physiol 2004, 198:359-369. 10.1002/jcp.10417, 14755541.
44. Ronaldson PT, Demarco KM, Sanchez-Covarrubias L, Solinsky CM, Davis TP. Transforming growth factor-beta signaling alters substrate permeability and tight junction protein expression at the blood-brain barrier during inflammatory pain. J Cereb Blood Flow Metab 2009, 29:1084-98. 10.1038/jcbfm.2009.32, 19319146.
45. Lochhead JJ, McCaffrey G, Quigley CE, Finch J, DeMarco KM, Nametz N, Davis TP. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab 2010, 30:1625-1636. 10.1038/jcbfm.2010.29, 20234382.
46. Willis CL, Meske DS, Davis TP. Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J Cereb Blood Flow Metab 2010, 30:1847-1859. 10.1038/jcbfm.2010.119, 20700133.
47. Lyck R, Ruderisch N, Moll AG, Steiner O, Cohen CD, Engelhardt B, Makrides V, Verrey F. Culture-induced changes in blood-brain barrier transcriptome: implications for amino-acid transporters in vivo. J Cereb Blood Flow Metab 2009, 29:1491-1502. 10.1038/jcbfm.2009.72, 19491922.
48. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008, 28:223-232. 10.1161/ATVBAHA.107.158014, 18162609.
49. Meng W, Takeichi M. Adherens junction: molecular architecture and regulation. Cold Spring Harb Perspect Biol 2009, 1:a002899. 10.1101/cshperspect.a002899, 20457565.
50. Williams MJ, Lowrie MB, Bennett JP, Firth JA, Clark P. Cadherin-10 is a novel blood-brain barrier adhesion molecule in human and mouse. Brain Res 2005, 1058:62-72. 10.1016/j.brainres.2005.07.078, 16181616.
51. Lampugnani MG, Dejana E. Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis. Thromb Res 2007, 120:S1-S6. 10.1016/S0049-3848(07)70124-X, 18023702.
52. Lippoldt A, Jansson A, Kniesel U, Andbjer B, Andersson A, Wolburg H, Fuxe K, Haller H. Phorbol ester induced changes in tight and adherens junctions in the choroid plexus epithelium and in the ependyma. Brain Res 2000, 854:197-206. 10.1016/S0006-8993(99)02355-0, 10784122.
53. Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 2001, 42:1007-1017.
54. Dwyer DS, Vannucci SJ, Simpson IA. Expression, regulation, and functional role of glucose transporters (GLUTs) in brain. Int Rev Neurobiol 2002, 51:159-88. 10.1016/S0074-7742(02)51005-9, 12420359.
55. Hawkins RA, O'Kane RL, Simpson IA, Vina JR. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr 2006, 136:218S-226S.
56. Kido Y, Tamai I, Okamoto M, Suzuki F, Tsuji A. Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies. Pharm Res 2000, 17:55-62. 10.1023/A:1007518525161, 10714609.
57. Spector R, Johanson CE. Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E. J Neurochem 2007, 103:425-438. 10.1111/j.1471-4159.2007.04773.x, 17645457.
58. Isakovic AJ, Abbott NJ, Redzic ZB. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat. J Neurochem 2004, 90:272-86. 10.1111/j.1471-4159.2004.02439.x, 15228584.
59. Redzic ZB, Biringer J, Barnes K, Baldwin SA, Al-Sarraf H, Nicola PA, Young JD, Cass CE, Barrand MA, Hladky SB. Polarized distribution of nucleoside transporters in rat brain endothelial and choroid plexus epithelial cells. J Neurochem 2005, 94:1420-1426. 10.1111/j.1471-4159.2005.03312.x, 16111480.
60. Isakovic AJ, Dencic SM, Segal MB, Redzic ZB. Transport of [14C]hypoxanthine by sheep choroid plexus epithelium as a monolayer in primary culture: Na+-dependent and Na+-independent uptake by the apical membrane and rapid intracellular metabolic conversion to nucleotides. Neurosci Lett 2008, 431:135-140. 10.1016/j.neulet.2007.11.029, 18164814.
61. Redzic ZB, Malatiali SA, Craik JD, Rakic ML, Isakovic AJ. Blood-brain barrier efflux transport of pyrimidine nucleosides and nucleobases in the rat. Neurochem Res 2009, 34:566-573. 10.1007/s11064-008-9823-5, 18751895.
62. Simpson IA, Carruthers A, Vannucci SJ. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab 2007, 27:1766-1791. 10.1038/sj.jcbfm.9600521, 2094104, 17579656.
63. Tsacopoulos M, Magistretti PJ. Metabolic coupling between glia and neurons. J Neurosci 1996, 16:877-885.
64. Abi-Saab WM, Maggs DG, Jones T, Jacob R, Srihari V, Thompson J, Kerr D, Leone P, Krystal JH, Spencer DD, During MJ, Sherwin RS. Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab 2002, 22:271-9. 10.1097/00004647-200203000-00004, 11891432.
65. Mueckler M, Caruso C, Baldwin SA, Panico M, Blench I, Morris HR, Allard WJ, Lienhard GE, Lodish HF. Sequence and structure of human glucose transporter. Science 1985, 229:941-945. 10.1126/science.3839598, 3839598.
66. Kayano T, Fukumoto H, Eddy RL, Fan YS, Byers MG, Shows TB, Bell GI. Evidence for a family of human glucose transporter-like proteins. Sequence and gene localization of a protein expressed in fetal skeletal muscle and other tissues. J Biol Chem 1988, 263:15245-15248.
67. Doege H, Schürmann A, Bahrenberg G, Brauers A, Joost HG. Glucose transporter 8 (GLUT8): a novel sugar facilitator with glucose transport activity. J Biol Chem 2000, 275:16275-16280. 10.1074/jbc.275.21.16275, 10821868.
68. Olson AL, Pessin JE. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu Rev Nutr 1996, 16:235-256. 10.1146/annurev.nu.16.070196.001315, 8839927.
69. Nishimura H, Pallardo FV, Seidner GA, Vannucci S, Simpson IA, Birnbaum MJ. Kinetics of GLUT1 and GLUT4 glucose transporters expressed in Xenopus oocytes. J Biol Chem 1993, 268:8514-8520.
70. Duarte JM, Morgenthaler FD, Lei H, Poitry-Yamate C, Gruetter R. Steady-state brain glucose transport kinetics re-evaluated with a four-state conformational model. Front Neuroenergetics 2009, 1:6. 2795468, 20027232.
71. Maher F, Vannucci SJ, Simpson IA. Glucose transporter proteins in brain. FASEB J 1994, 8:1003-1010.
72. Kumagai AK, Dwyer KJ, Pardridge WM. Differential glycosylation of the GLUT1 glucose transporter in brain capillaries and choroid plexus. Biochim Biophys Acta 1994, 1193:24-30. 10.1016/0005-2736(94)90328-X, 8038191.
73. Semenza GL. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem J 2007, 405:1-9.
74. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000, 88:1474-1480.
75. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001, 294:1337-1340. 10.1126/science.1066373, 11598268.
76. Chavez JC, LaManna JC. Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J Neurosci 1993, 22:8922-8931.
77. Vemula S, Roder KE, Yang T, Bhat GJ, Thekkumkara TJ, Abbruscato TJ. A functional role for sodium-dependent glucose transport across the blood-brain barrier during oxygen glucose deprivation. J Pharmacol Exp Ther 2009, 328:487-495. 10.1124/jpet.108.146589, 2630371,2630371, 18981287.
78. Guo X, Geng M, Du G. Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood-brain barrier. Biochem Genet 2005, 43:175-87. 10.1007/s10528-005-1510-5, 15932065.
79. Rotstein M, Engelstad K, Yang H, Wang D, Levy B, Chung WK, De Vivo DC. Glut1 deficiency: Inheritance pattern determined by haploinsufficiency. Ann Neurol 2010,
80. Klepper J, Leiendecker B. GLUT1 deficiency syndrome--2007 update. Dev Med Child Neurol 2007, 49:707-16. 10.1111/j.1469-8749.2007.00707.x, 17718830.
81. Brockmann K. The expanding phenotype of GLUT1-deficiency syndrome. Brain Dev 2009, 31:545-552. 10.1016/j.braindev.2009.02.008, 19304421.
82. Wang D, Pascual JM, Yang H, Engelstad K, Mao X, Cheng J, Yoo J, Noebels JL, De Vivo DC. A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet 1993, 15:1169-1179.
83. Mooradian AD, Chung HC, Shah GN. GLUT-1 expression in the cerebra of patients with Alzheimer's disease. Neurobiol Aging 1993, 18:469-474.
84. Hunt A, Schonknecht P, Henze M, Seidl U, Haberkorn U, Schroder J. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease. Psychiatry Res 155:147-154.
85. Mosconi L, De Santi S, Li J, Tsui WH, Li Y, Boppana M, Laska E, Rusinek H, de Leon MJ. Hippocampal hypometabolism predicts cognitive decline from normal aging. Neurobiol Aging 2008, 29:676-692. 10.1016/j.neurobiolaging.2006.12.008, 2430185, 17222480.
86. Régina A, Morchoisne S, Borson ND, McCall AL, Drewes LR, Roux F. Factor(s) released by glucose-deprived astrocytes enhance glucose transporter expression and activity in rat brain endothelial cells. Biochim Biophys Acta 2001, 1540:233-242.
87. Yeh WL, Lin CJ, Fu WM. Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol Pharmacol 2008, 73:170-177. 10.1124/mol.107.038851, 17942749.
88. Deane R, Segal MB. The transport of sugars across the perfused choroid plexus of the sheep. J Physiol 1985, 362:245-260. 1192893, 4020688.
89. Gerhart DZ, LeVasseur RJ, Broderius MA, Drewes LR. Glucose transporter localization in brain using light and electron immunocytochemistry. J Neurosci Res 1989, 22:464-472. 10.1002/jnr.490220413, 2668543.
90. Harik SI, Kalaria RN, Andersson L, Lundahl P, Perry G. Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions. J Neurosci 1990, 10:3862-3872.
91. Fields HM, Rinaman L, Devaskar SU. Distribution of glucose transporter isoform-3 and hexokinase I in the postnatal murine brain. Brain Res 1999, 846:260-264. 10.1016/S0006-8993(99)01979-4, 10556644.
92. Arluison M, Quignon M, Nguyen P, Thorens B, Leloup C, Penicaud L. Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain--an immunohistochemical study. J Chem Neuroanat 2004, 28:117-36. 10.1016/j.jchemneu.2004.05.009, 15482899.
93. Cornford EM, Hyman S, Cornford ME, Damian RT. Glut1 glucose transporter in the primate choroid plexus endothelium. J Neuropathol Exp Neurol 1998, 57:404-414. 10.1097/00005072-199805000-00004, 9596411.
94. Pardridge WM. Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev 1983, 63:1481-1535.
95. Wurtman RJ, Moskowitz MA, Munro HN. Transsynaptic control of neuronal protein synthesis. The Neurosciences: Fourth Study Program 1979, 897-909. Cambridge: MIT Press, Schmitt FO, Norden FG.
96. Verrey F. System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch 2003, 445:529-533.
97. Nakamura E, Sato M, Yang H, Miyagawa F, Harasaki M, Tomita K, Matsuoka S, Noma A, Iwai K, Minato N. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem 1999, 274:3009-3016. 10.1074/jbc.274.5.3009, 9915839.
98. Estévez R, Camps M, Rojas AM, Testar X, Devés R, Hediger MA, Zorzano A, Palacín M. The amino acid transport system y+L/4F2hc is a heteromultimeric complex. FASEB J 1998, 12:1319-1329.
99. Bröer S, Bröer A, Hamprecht B. Expression of the surface antigen 4F2hc affects system-L-like neutral-amino-acid-transport activity in mammalian cells. Biochem J 1997, 324:535-541. 1218463, 9182715.
100. Kido Y, Tamai I, Uchino H, Suzuki F, Sai Y, Tsuji A. Molecular and functional identification of large neutral amino acid transporters LAT1 and LAT2 and their pharmacological relevance at the blood-brain barrier. J Pharm Pharmacol 2001, 53:497-503. 10.1211/0022357011775794, 11341366.
101. Smith QR, Momma S, Aoyagi M, Rapoport SI. Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 1987, 49:1651-1658. 10.1111/j.1471-4159.1987.tb01039.x, 3668544.
102. Stoll J, Wadhwani KC, Smith QR. Identification of the cationic amino acid transporter (System y+) of the rat blood-brain barrier. J Neurochem 1993, 60:1956-1959. 10.1111/j.1471-4159.1993.tb13428.x, 8473910.
103. Betz AL, Goldstein GW. Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries. Science 1978, 202:225-226. 10.1126/science.211586, 211586.
104. Tayarani I, Lefauconnier J-M, Roux F, Bourrer J-M. Evidence for alanine, serine, and cystine system of transport in isolated brain capillaries. J Cereb Blood Flow Metab 1987, 7:585-591.
105. Sánchez del Pino MM, Peterson DR, Hawkins RA. Neutral amino acid transport characterization of isolated luminal and abluminal membranes of the blood-brain barrier. J Biol Chem 1995, 270:14913-14918.
106. Lee WJ, Hawkins RA, Viña JR, Peterson DR. Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal. Am J Physiol Cell Physiol 1998, 274:C1101-C1107.
107. O'Kane RL, Martinez-Lopez I, DeJoseph MR, Viña JR, Hawkins RA. Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J Biol Chem 1999, 274:31891-31895.
108. Stegink LD, Filer LJ, Baker GL. Plasma amino acid concentrations in normal adults fed meals with added monosodium L-glutamate and aspartame. J Nutr 1983, 113:1851-1860.
109. Benveniste H, Drejer J, Schousboe A, Diemer NH. Elevations of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 1984, 43:1369-1374. 10.1111/j.1471-4159.1984.tb05396.x, 6149259.
110. Hawkins RA. The blood-brain barrier and glutamate. Am J Clin Nutr 2009, 90:867S-874S. 10.3945/ajcn.2009.27462BB, 19571220.
111. Zlotnik A, Gurevich B, Tkachov S, Maoz I, Shapira Y, Teichberg VI. Brain neuroprotection by scavenging blood glutamate. Exp Neurol 2007, 203:213-220. 10.1016/j.expneurol.2006.08.021, 17014847.
112. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 2010, 37:13-25. 10.1016/j.nbd.2009.07.030, 19664713.
113. Segal MB, Preston JE, Collis CS, Zlokovic BV. Kinetics and Na independence of amino acid uptake by blood side of perfused sheep choroid plexus. Am J Physiol 1990, 258:F1288-F1294.
114. Duelli R, Enerson BE, Gerhart DZ, Drewes LR. Expression of large amino acid transporter LAT1 in rat brain endothelium. J Cereb Blood Flow Metab 2000, 20:1557-1562. 10.1097/00004647-200011000-00005, 11083230.
115. Preston JE, Segal MB. The uptake of anionic and cationic amino acids by the isolated perfused sheep choroid plexus. Brain Res 1992, 581:351-355. 10.1016/0006-8993(92)90731-N, 1393540.
116. Keep RF, Xiang J. N-system amino acid transport at the blood--CSF barrier. J Neurochem 1995, 65:2571-2576. 10.1046/j.1471-4159.1995.65062571.x, 7595553.
117. Agulhon C, Rostaing P, Ravassard P, Sagné C, Triller A, Giros B. Lysosomal amino acid transporter LYAAT-1 in the rat central nervous system: an in situ hybridization and immunohistochemical study. J Comp Neurol 2003, 462:71-89. 10.1002/cne.10712, 12761825.
118. Al-Sarraf H, Preston JE, Segal MB. Acidic amino acid accumulation by rat choroid plexus during development. Brain Res Dev Brain Res 1997, 102:47-52. 10.1016/S0165-3806(97)00075-8, 9298233.
119. Beschorner R, Pantazis G, Jeibmann A, Boy J, Meyermann R, Mittelbronn M, Schittenhelm J. Expression of EAAT-1 distinguishes choroid plexus tumors from normal and reactive choroid plexus epithelium. Acta Neuropathol 2009, 117:667-675. 10.1007/s00401-009-0519-y, 19283393.
120. Pellerin E, Magistretti PJ. Food for thought: challenging the dogmas. J Cereb Blood Flow Metab 2003, 23:1282-1286. 10.1097/01.WCB.0000096064.12129.3D, 14600434.
121. Adle-Biassette H, Olivier P, Verney C, Fontaine RH, Evrard P, Hénin D, Massias L, Gressens P, Baud O. Cortical consequences of in vivo blockade of monocarboxylate transport during brain development in mice. Pediatr Res 2007, 61:54-60. 10.1203/01.pdr.0000250040.61888.61, 17211141.
122. Poole RC, Halestrap AP. Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am J Physiol 1993, 264:C761-C782.
123. Halestrap AP, Meredith D. The SLC16 gene family: from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch 2004, 447:619-628. 10.1007/s00424-003-1067-2, 12739169.
124. Bergersen LH. Is lactate food for neurons? Comparison of monocarboxylate transporter subtypes in brain and muscle. Neuroscience 2007, 145:11-19. 10.1016/j.neuroscience.2006.11.062, 17218064.
125. Bergersen L, Wærhaug O, Helm J, Thomas M, Laake P, Davies AJ, Wilson MC, Halestrap AP, Ottersen OP. A novel postsynaptic density protein: the monocarboxylate transporter MCT2 is colocalized with delta 2 glutamate receptors in postsynaptic densities of parallel fiber-Purkinje cell synapses. Exp Brain Res 2001, 136:523-534. 10.1007/s002210000600, 11291733.
126. Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, Mengesha W, Raman C, Zerangue N. Expression of the thyroid hormone transporters monocarboxylate transporter-8 (SLC16A2) and organic ion transporter-14 (SLCO1C1) at the blood-brain barrier. Endocrinology 2008, 149:6251-6261. 10.1210/en.2008-0378, 18687783.
127. Schwartz CE, Stevenson RE. The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome. Best Pract Res Clin Endocrinol Metab 2007, 21:307-321. 10.1016/j.beem.2007.03.009, 2094733, 17574010.
128. Puchowicz MA, Xu K, Sun X, Ivy A, Emancipator D, LaManna JC. Diet-induced ketosis increases capillary density without altered blood flow in rat brain. Am J Physiol Endocrinol Metab 2006, 292:E1607-E1615.
129. Leino RL, Gerhart DZ, Drewes LR. Monocarboxylate transporter (MCT1) abundance in brains of suckling and adult rats: a quantitative electron microscopic immunogold study. Brain Res Dev Brain Res 1999, 113:47-54. 10.1016/S0165-3806(98)00188-6, 10064873.
130. Koehler-Stec EM, Simpson IA, Vannucci SJ, Landschulz KT, Landschulz WH. Monocarboxylate transporter expression in mouse brain. Am J Physiol 1998, 275:E516-E524.
131. Permanne B, Adessi C, Saborio GP, Fraga S, Frossard MJ, Van Dorpe J, Dewachter I, Banks WA, Van Leuven F, Soto C. Reduction of amyloid load and cerebral damage in a transgenic mouse model of Alzheimer's disease by treatment with a beta-sheet breaker peptide. FASEB J 2002, 16:860-862.
132. Tuszynski MH, Blesch A. Nerve growth factor: from animal models of cholinergic neuronal degeneration to gene therapy in Alzheimer's disease. Prog Brain Res 2004, 146:441-449.
133. Dawbarn D, Allen SJ. Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 2003, 29:211-230. 10.1046/j.1365-2990.2003.00487.x, 12787319.
134. Espejo M, Cutillas B, Arenas TE, Ambrosio S. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor. Cell Transplant 2000, 9:45-53.
135. Guan J, Krishnamurthi R, Waldvogel HJ, Faull RL, Clark R, Gluckman P. N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats. Brain Res 2000, 859:286-292. 10.1016/S0006-8993(00)01988-0, 10719076.
136. Brasnjevic I, Steinbusch HW, Schmitz C, Martinez-Martinez P. Delivery of peptide and protein drugs over the blood-brain barrier. Prog Neurobiol 2009, 87:212-251. 10.1016/j.pneurobio.2008.12.002, 19395337.
137. Zlokovic BV, Begley D, Chain DG. Blood-brain barrier permeability to dipeptides and their constituent amino acids. Brain Res 1983, 271:65-71. 10.1016/0006-8993(83)91365-3, 6883121.
138. Rubio-Aliaga I, Daniel H. Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica 2008, 38:1022-1042. 10.1080/00498250701875254, 18668438.
139. Zlokovic BV, Hyman S, McComb JG, Lipovac MN, Tang G, Davson H. Kinetics of arginine-vasopressin uptake at the blood-brain barrier. Biochim Biophys Acta 1990, 1025:191-198. 10.1016/0005-2736(90)90097-8, 2364078.
140. Zlokovic BV, Lipovac MN, Begley DJ, Davson H, Rakic L. Transport of leucine-enkephalin across the blood-brain barrier in the perfused guinea pig brain. J Neurochem 1987, 49:310-315. 10.1111/j.1471-4159.1987.tb03431.x, 3585338.
141. Zlokovic BV, Mackic JB, Djuricic B, Davson H. Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood-brain barrier in an in situ perfused guinea-pig brain. J Neurochem 1989, 53:1333-1340. 10.1111/j.1471-4159.1989.tb08522.x, 2795003.
142. Zlokovic BV. Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier. Pharm Res 1995, 12:1395-1406. 10.1023/A:1016254514167, 8584471.
143. Banks WA, Kastin AJ. A brain-to-blood carrier-mediated transport system for small, N-tyrosinated peptides. Pharmacol Biochem Behav 1984, 21:943-946. 10.1016/S0091-3057(84)80077-5, 6151670.
144. Banks WA. The CNS as a target for peptides and peptide-based drugs. Expert Opin Drug Deliv 2006, 3:707-712. 10.1517/17425247.3.6.707, 17076593.
145. Dogrukol-Ak D, Kumar VB, Ryerse JS, Farr SA, Verma S, Nonaka N, Nakamachi T, Ohtaki H, Niehoff ML, Edwards JC, Shioda S, Morley JE, Banks WA. Isolation of peptide transport system-6 from brain endothelial cells: therapeutic effects with antisense inhibition in Alzheimer and stroke models. J Cereb Blood Flow Metab 2009, 29:411-422. 10.1038/jcbfm.2008.131, 19002200.
146. Brownlees J, Williams CH. Peptidases, peptides, and the mammalian blood-brain barrier. J Neurochem 1993, 60:793-803. 10.1111/j.1471-4159.1993.tb03223.x, 8436970.
147. Banks WA, Kastin AJ. CSF-plasma relationships for DSIP and some other neuropeptides. Pharmacol Biochem Behav 1983, 19:1037-1040. 10.1016/0091-3057(83)90412-4, 6689211.
148. Woods SC, Seeley RJ, Baskin DG, Schwartz MW. Insulin and the blood-brain barrier. Curr Pharm Des 2003, 9:795-800. 10.2174/1381612033455323, 12678878.
149. Broadwell RD, Baker-Cairns BJ, Friden PM, Oliver C, Villegas JC. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor. Exp Neurol 1996, 142:47-65. 10.1006/exnr.1996.0178, 8912898.
150. Banks WA, Farr SA, La Scola ME, Morley JE. Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther 2001, 299:536-541.
151. Zlokovic BV, Jovanovic S, Miao W, Samara S, Verma S, Farrell CL. Differential regulation of leptin transport by the choroid plexus and blood-brain barrier and high affinity transport systems for entry into hypothalamus and across the blood-cerebrospinal fluid barrier. Endocrinology 2000, 141:1434-1441. 10.1210/en.141.4.1434, 10746647.
152. Banks WA, Farrell CL. Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible. Am J Physiol Endocrinol Metab 2003, 285:E10-E15.
153. Deane R, Sagare A, Hamm K, Parisi M, LaRue B, Guo H, Wu Z, Holtzman DM, Zlokovic BV. IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor. J Neurosci 2005, 25:11495-11503. 10.1523/JNEUROSCI.3697-05.2005, 16354907.
154. Nishijima T, Piriz J, Duflot S, Fernandez AM, Gaitan G, Gomez-Pinedo U, Verdugo JM, Leroy F, Soya H, Nuñez A, Torres-Aleman I. Neuronal activity drives localized blood-brain-barrier transport of serum insulin-like growth factor-I into the CNS. Neuron 2010, 67:834-846. 10.1016/j.neuron.2010.08.007, 20826314.
155. Biere AL, Ostaszewski B, Stimson ER, Hyman BT, Maggio JE, Selkoe DJ. Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J Biol Chem 1996, 271:32916-32922. 10.1074/jbc.271.51.32916, 8955133.
156. Calero M, Rostagno A, Matsubara E, Zlokovic B, Frangione B, Ghiso J. Apolipoprotein J (clusterin) and Alzheimer's disease. Microsc Res Tech 2000, 50:305-315. 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L, 10936885.
157. Sagare A, Deane R, Bell RD, Johnson B, Hamm K, Pendu R, Marky A, Lenting PJ, Wu Z, Zarcone T, Goate A, Mayo K, Perlmutter D, Coma M, Zhong Z, Zlokovic BV. Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med 2007, 13:1029-1031. 10.1038/nm1635, 2936449, 17694066.
158. Deane R, Bell RD, Sagare A, Zlokovic BV. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. CNS Neurol Disord Drug Targets 2009, 8:16-30. 10.2174/187152709787601867, 2872930, 19275634.
159. Yan SF, Ravichandran R, Schmidt AM. The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 2010, 106:842-853. 10.1161/CIRCRESAHA.109.212217, 20299674.
160. Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA. Low density lipoprotein receptor related protein-1: A serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain. J Neurochem 2010, 115:1077-1089. 10.1111/j.1471-4159.2010.07002.x, 2972355, 20854368.
161. Deane R, Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, Hu HW, Spijkers P, Guo H, Song X, Lenting PJ, Van Nostrand WE, Zlokovic BV. LRP/amyloid b-peptide interaction mediates differential brain efflux of Ab isoforms. Neuron 2004, 43:333-344. 10.1016/j.neuron.2004.07.017, 15294142.
162. Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, Deane R, Zlokovic BV. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 2007, 27:909-918. 2853021, 17077814.
163. Ito S, Ueno T, Ohtsuki S, Terasaki T. Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-b peptide(1-40) in mouse: involvement of an LRP-1-independent pathway. J Neurochem 2010, 113:1356-1363.
164. Banks WA. Delivery of peptides to the brain: emphasis on therapeutic development. Biopolymers 2008, 90:589-594. 10.1002/bip.20980, 18335425.
165. Broadwell RD. Transcytosis of macromolecules through the blood-brain barrier: a cell biological perspective and critical appraisal. Acta Neuropathol 1989, 79:117-128. 10.1007/BF00294368, 2688350.
166. Bodor N, Buchwald P. Brain-targeted drug delivery: experiences to date. Am J Drug Deliv 2003, 1:13-26.
167. Levin VA. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem 1980, 23:682-684. 10.1021/jm00180a022, 7392035.
168. Banks WA, Kastin AJ. Editorial review: Peptide transport systems for opiates across the blood- brain barrier. Am J Physiol 1990, 259:E1-E10.
169. King M, Su W, Chang A, Zuckerman A, Pasternak GW. Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat Neurosci 2001, 4:221-222. 10.1038/85115, 11224531.
170. Boado RJ, Zhang Y, Wang Y, Pardridge WM. Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse. Biotechnol Bioeng 2009, 102:1251-1258. 10.1002/bit.22135, 2729652, 18942151.
171. van Rooy I, Cakir-Tascioglu S, Couraud PO, Romero IA, Weksler B, Storm G, Hennink WE, Schiffelers RM, Mastrobattista E. Identification of peptide ligands for targeting to the blood-brain barrier. Pharm Res 2010, 27:673-682. 10.1007/s11095-010-0053-6, 2837178, 20162339.
172. Szmydynger-Chodobska J, Fox LM, Lynch KM, Zink BJ, Chodobski A. Vasopressin amplifies the production of proinflammatory mediators in traumatic brain injury. J Neurotrauma 2010, 27:1449-1461. 10.1089/neu.2010.1331, 20504162.
173. Ocheltree SM, Shen H, Hu Y, Xiang J, Keep RF, Smith DE. Role of PEPT2 in the choroid plexus uptake of glycylsarcosine and 5-aminolevulinic acid: studies in wild-type and null mice. Pharm Res 2004, 21:1680-1685. 10.1023/B:PHAM.0000041465.89254.05, 15497696.
174. Yamashita T, Shimada S, Guo W, Sato K, Kohmura E, Hayakawa T, Takagi T, Tohyama M. Cloning and functional expression of a brain peptide/histidine transporter. J Biol Chem 1997, 272:10205-10211. 10.1074/jbc.272.17.11408, 9092568.
175. Ocheltree SM, Shen H, Hu Y, Keep RF, Smith DE. Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice. J Pharmacol Exp Ther 2005, 315:240-247. 10.1124/jpet.105.089359, 15987832.
176. Shu C, Shen H, Teuscher NS, Lorenzi PJ, Keep RF, Smith DE. Role of PEPT2 in peptide/mimetic trafficking at the blood-cerebrospinal fluid barrier: studies in rat choroid plexus epithelial cells in primary culture. J Pharmacol Exp Ther 2002, 301:820-829. 10.1124/jpet.301.3.820, 12023509.
177. Berger UV, Hediger MA. Distribution of peptide transporter PEPT2 mRNA in the rat nervous system. Anat Embryol (Berl) 1999, 199:439-449. 10.1007/s004290050242, 10221455.
178. Dietrich MO, Spuch C, Antequera D, Rodal I, de Yébenes JG, Molina JA, Bermejo F, Carro E. Megalin mediates the transport of leptin across the blood-CSF barrier. Neurobiol Aging 2008, 29:902-912. 10.1016/j.neurobiolaging.2007.01.008, 17324488.
179. Alvira-Botero X, Carro EM. Clearance of amyloid- peptide across the choroid plexus in Alzheimer's disease. Curr Aging Sci 2010,
180. Behl M, Zhang Y, Shi Y, Cheng J, Du Y, Zheng W. Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C. Neurotoxicology 2010, 31:524-532. 10.1016/j.neuro.2010.05.004, 20488202.
181. Johanson CE, Duncan JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: New challenges in health and disease. Cerebrospinal Fluid Res 2008, 5:10. 10.1186/1743-8454-5-10, 18479516.
182. Johanson CE, Donahue JE, Spangenberger A, Stopa EG, Duncan JA, Sharma HS. Atrial natriuretic peptide: its putative role in modulating the choroid plexus-CSF system for intracranial pressure regulation. Acta Neurochir Suppl 2006, 96:451-456. full_text, 16671503.
183. Mori K, Tsutsumi K, Kurihara M, Kawaguchi T, Niwa M. Alteration of atrial natriuretic peptide receptors in the choroid plexus of rats with induced or congenital hydrocephalus. Childs Nerv Syst 1990, 6:190-193. 10.1007/BF01850969, 2166621.
184. Chodobski A, Loh YP, Corsetti S, Szmydynger-Chodobska J, Johanson CE, Lim YP, Monfils PR. The presence of arginine vasopressin and its mRNA in rat choroid plexus epithelium. Brain Res Mol Brain Res 1997, 48:67-72. 10.1016/S0169-328X(97)00079-X, 9379851.
185. Szmydynger-Chodobska J, Chung I, Chodobski A. Chronic hypernatremia increases the expression of vasopressin and voltage-gated Na channels in the rat choroid plexus. Neuroendocrinology 2006, 84:339-345.
186. Chodobski A, Szmydynger-Chodobska J, Johanson CE. Vasopressin mediates the inhibitory effect of central angiotensin II on cerebrospinal fluid formation. Eur J Pharmacol 1998, 347:205-209. 10.1016/S0014-2999(98)00229-5, 9653883.
187. Johanson CE, Preston JE, Chodobski A, Stopa EG, Szmydynger-Chodobska J, McMillan PN. AVP V1 receptor-mediated decrease in Cl- efflux and increase in dark cell number in choroid plexus epithelium. Am J Physiol 1999, 276:C82-C90.
188. Johanson C, Stopa E, Baird A, Sharma H. Traumatic brain injury and recovery mechanisms: peptide modulation of periventricular neurogenic regions by the choroid plexus-CSF nexus. J Neural Transm 2010,
189. Schreiber G. The evolution of transthyretin synthesis in the choroid plexus. Clin Chem Lab Med 2002, 40:1200-1210. 10.1515/CCLM.2002.210, 12553420.
190. Palha JA, Hays MT, de Escobar GM, Episkopou V, Gottesman ME, Saraiva MHM. Transthyretin is not essential for thyroxine to reach the brain and other tissues in transthyretin-null mice. Am J Physiol 1997, 272:E485-E493.
191. Quintela T, Alves CH, Gonçalves I, Baltazar G, Saraiva MJ, Santos CR. 5Alpha-dihydrotestosterone up-regulates transthyretin levels in mice and rat choroid plexus via an androgen receptor independent pathway. Brain Res 2008, 1229:18-26. 10.1016/j.brainres.2008.06.095, 18634756.
192. Tang YP, Haslam SZ, Conrad SE, Sisk CL. Estrogen increases brain expression of the mRNA encoding transthyretin, an amyloid beta scavenger protein. J Alzheimers Dis 2004, 6:413-420.
193. Quintela T, Gonçalves I, Baltazar G, Alves CH, Saraiva MJ, Santos CR. 17beta-estradiol induces transthyretin expression in murine choroid plexus via an oestrogen receptor dependent pathway. Cell Mol Neurobiol 2009, 29:475-483. 10.1007/s10571-008-9339-1, 19130215.
194. Quintela T, Gonçalves I, Martinho A, Alves CH, Saraiva MJ, Rocha P, Santos CR. Progesterone enhances transthyretin expression in the rat choroid plexus in vitro and in vivo via progesterone receptor. J Mol Neurosci 2010,
195. Schinkel AH, Jonker JW. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview:. Adv Drug Deliv Rev 2003, 55:3-29. 10.1016/S0169-409X(02)00169-2, 12535572.
196. Sauna ZE, Smith MM, Muller M, Kerr KM, Ambudkar SM. The mechanism of action of multidrug-resistance- linked P-glycoprotein. J Bioenerg Biomembranes 2001, 33:481-491.
197. Russel FG, Masereeuw R, van Aubel RA. Molecular aspects of renal anionic drug transport. Ann Rev Physiol 2002, 64:563-594.
198. Dresser MJ, Leabman MK, Giacomini KM. Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters. J Pharm Sci 2001, 90:397-421. 10.1002/1520-6017(200104)90:4<397::AID-JPS1000>3.0.CO;2-D, 11170032.
199. Roberts LM, Black DS, Raman C, Woodford K, Zhou M, Haggerty JE, Yan AT, Cwirla SE, Grindstaff KK. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation. Neuroscience 2008, 155:423-438. 10.1016/j.neuroscience.2008.06.015, 18619525.
200. Babakhanian K, Bendayan M, Bendayan R. Localization of P-glycoprotein at the nuclear envelope of rat brain cells. Biochem Biophys Res Commun 2007, 361:301-306. 10.1016/j.bbrc.2007.06.176, 17651695.
201. Schinkel A, Mayer U, Wagenaar E, Mol C, van Deemter L, Smit J, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE, Borst P. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 1997, 94:4028-4033. 10.1073/pnas.94.8.4028, 20562, 9108099.
202. Linnet K, Ejsing T. A review on the impact of P-glycoprotein on the penetration of drugs into the brain. Focus on psychotropic drugs. Eur Neuropsychopharmacol 2008, 18:157-169. 10.1016/j.euroneuro.2007.06.003, 17683917.
203. Miller DS. Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol Sci 2010, 31:246-54. 10.1016/j.tips.2010.03.003, 20417575.
204. Eyal S, Hsiao P, Unadkat JD. Drug interactions at the blood-brain barrier: fact or fantasy?. Pharmacol Ther 2009, 123:80-104. 10.1016/j.pharmthera.2009.03.017, 2751796, 19393264.
205. Calatozzolo C, Gelati M, Ciusani E, Sciacca F, Pollo B, Cajola L, Marras C, Silvani A, Vitellaro-Zuccarello L, Croci D, Boiardi A, Salmaggi A. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma. J Neurooncol 2005, 74:113-121. 10.1007/s11060-004-6152-7, 16193381.
206. Zhang W, Mojsilovic-Petrovic J, Andrade M, Zhang H, Ball M, Stanimirovic D. The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J 2003, 17:2085-2087.
207. Dauchy S, Dutheil F, Weaver R, Chassoux F, Daumas-Duport C, Couraud P, Scherrmann JM, De Waziers I, Declèves X. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier. J Neurochem 2008, 107:1518-1528. 10.1111/j.1471-4159.2008.05720.x, 19094056.
208. Westholm D, Rumbley J, Salo D, Rich T, Anderson G. Organic anion-transporting polypeptides at the blood-brain and blood-cerebrospinal fluid barriers. Curr Top Dev Biol 2008, 80:135-170. full_text, 17950374.
209. Bronger H, König J, Kopplow K, Steiner H, Ahmadi R, Herold-Mende C, Keppler D, Nies AT. ABCC drug efflux pumps and organic anion uptake transporters in human gliomas and the blood- tumor barrier. Cancer Res 2005, 65:11419-11428. 10.1158/0008-5472.CAN-05-1271, 16357150.
210. Mori S, Ohtsuki S, Takanaga H, Kikkawa T, Kang Y, Terasaki T. Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs. J Neurochem 2004, 90:931-941. 10.1111/j.1471-4159.2004.02552.x, 15287899.
211. Alebouyeh M, Takeda M, Onozato M, Tojo A, Noshiro R, Hasannejad H, Inatomi J, Narikawa S, Huang XL, Khamdang S, Anzai N, Endou H. Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites. J Pharmacol Sci 2003, 93:430-436. 10.1254/jphs.93.430, 14737013.
212. Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 2007, 24:1227-1251. 10.1007/s11095-007-9254-z, 17473959.
213. Miecz D, Januszewicz E, Czeredys M, Hinton B, Berezowski V, Cecchelli R, Nałecz KA. Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier. J Neurochem 2008, 104:113-123.
214. Strazielle N, Khuth ST, Ghersi-Egea JF. Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations. Adv Drug Deliv Rev 2004, 56:1717-1740. 10.1016/j.addr.2004.07.006, 15381331.
215. Daood M, Tsai C, Ahdab-Barmada M, Watchko J. ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) Expression in the Developing Human CNS. Neuropediatrics 2008, 39:211-218. 10.1055/s-0028-1103272, 2821654, 19165709.
216. Rao VV, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli AC, Piwnica-Worms D. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci USA 1999, 96:3900-3905. 10.1073/pnas.96.7.3900, 22392, 10097135.
217. Gazzin S, Strazielle N, Schmitt C, Fevre-Montange M, Ostrow JD, Tiribelli C, Ghersi-Egea JF. Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces. J Comp Neurol 2008, 510:497-507. 10.1002/cne.21808, 18680196.
218. Nies A, Jedlitschky G, König J, Herold-Mende C, Steiner H, Schmitt H, Keppler D. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 2004, 129:349-360. 10.1016/j.neuroscience.2004.07.051, 15501592.
219. Lee YJ, Kusuhara H, Sugiyama Y. Do multidrug resistance-associated protein-1 and -2 play any role in the elimination of estradiol-17 beta-glucuronide and 2, 4-dinitrophenyl-S-glutathione across the blood-cerebrospinal fluid barrier?. J Pharm Sci 2004, 93:99-107. 10.1002/jps.10521, 14648640.
220. Tachikawa M, Watanabe M, Hori S, Fukaya M, Ohtsuki S, Asashima T, Terasaki T. Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain. J Neurochem 2005, 95:294-304. 10.1111/j.1471-4159.2005.03369.x, 16181433.
221. Gao B, Stieger B, Noe B, Fritschy JM, Meier PJ. Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J Histochem Cytochem 1999, 47:1255-1264.
222. Kusuhara H, He Z, Nagata Y, Nozaki Y, Ito T, Masuda H, Meier PJ, Abe T, Sugiyama Y. Expression and functional involvement of organic anion transporting polypeptide subtype 3 (Slc21a7) in rat choroid plexus. Pharm Res 2003, 20:720-727. 10.1023/A:1023473216759, 12751626.
223. Zhang H, Song YN, Liu WG, Guo XL, Yu LG. Regulation and role of organic anion-transporting polypeptides (OATPs) in drug delivery at the choroid plexus. J Clin Neurosci 2010, 17:679-684. 10.1016/j.jocn.2009.11.001, 20356750.
224. Choudhuri S, Cherrington NJ, Li N, Klaassen CD. Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metab Dispos 2003, 31:1337-1345. 10.1124/dmd.31.11.1337, 14570765.
225. Nagata Y, Kusuhara H, Endou H, Sugiyama Y. Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. Mol Pharmacol 2002, 61:982-988. 10.1124/mol.61.5.982, 11961115.
226. Bauer B, Hartz AM, Fricker G, Miller DS. Pregnane × receptor up-regulation of Pglycoprotein expression and transport function at the blood-brain barrier. Mol Pharmacol 2004, 66:413-419.
227. Bauer B, Yang X, Hartz AM, Olson ER, Zhao R, Kalvass JC, Pollack GM, Miller DS. In vivo activation of human pregnane × receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation. Mol Pharmacol 2006, 70:1212-1219. 10.1124/mol.106.023796, 16837625.
228. Roberts DJ, Goralski KB. A critical overview of the influence of inflammation and infection on P-glycoprotein expression and activity in the brain. Expert Opin Drug Metab Toxicol 2008, 4:1245-1264. 10.1517/17425255.4.10.1245, 18798696.
229. Bauer B, Hartz AM, Miller DS. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier. Mol Pharmacol 2007, 71:667-675. 10.1124/mol.106.029512, 17132686.
230. Hartz AM, Bauer B, Fricker G, Miller DS. Rapid modulation of P-glycoprotein-mediated transport at the blood-brain barrier by tumor necrosis factor-alpha and lipopolysaccharide. Mol Pharmacol 2006, 69:462-470. 10.1124/mol.105.017954, 16278373.
231. Hartz AM, Bauer B, Block ML, Hong JS, Miller DS. Diesel exhaust particles induce oxidative stress, proinflammatory signaling, and P-glycoprotein up-regulation at the blood-brain barrier. FASEB J 2008, 22:2723-2733. 10.1096/fj.08-106997, 2493447, 18474546.
232. Block ML, Wu X, Pei Z, Li G, Wang T, Qin L, Wilson B, Yang J, Hong JS, Veronesi B. Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J 2006, 18:1618-1620.
233. Tai LM, Loughlin AJ, Male DK, Romero IA. P-Glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta. J Cereb Blood Flow Metab 2009, 29:1079-1083. 10.1038/jcbfm.2009.42, 19367293.
234. Xiong H, Callaghan D, Jones A, Bai J, Rasquinha I, Smith C, Pei K, Walker D, Lue LF, Stanimirovic D, Zhang W. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Ab(1-40) peptides. J Neurosci 2009, 29:5463-5475. 10.1523/JNEUROSCI.5103-08.2009, 2745912, 19403814.
235. Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W, Kunert-Keil C, Walker LC, Warzok RW. Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 2002, 12:535-541. 10.1097/00008571-200210000-00005, 12360104.
236. Wijesuriya HC, Bullock JY, Faull RL, Hladky SB, Barrand MA. ABC efflux transporters in brain vasculature of Alzheimer's subjects. Brain Res 2010, 1358:228-238. 10.1016/j.brainres.2010.08.034, 20727860.
237. Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 2004, 45:545-552. 10.1016/j.neuint.2003.11.006, 15186921.
238. Cserr HF, DePasquale M, Patlak CS, Pullen RGL. Convection of cerebral interstitial fluid and its role in brain volume regulation. Ann N Y Acad Sci 1989, 481:123-134.
239. Vorbrodt AW. Ultrastructural cytochemistry of blood-brain barrier endothelia. Prog Histochem Cytochem 1988, 18:1-99.
240. Zlokovic BV, Mackic JB, Wang L, McComb JG, McDonough A. Differential expression of Na, K-ATPase alpha and beta subunit isoforms at the blood-brain barrier and the choroid plexus. J Biol Chem 1993, 268:8019-8025.
241. Lingrel JB. The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na, K-ATPase. Annu Rev Physiol 2010, 72:395-412. 10.1146/annurev-physiol-021909-135725, 20148682.
242. O'Donnell ME, Lam TI, Tran LQ. Estradiol reduces activity of the blood-brain barrier Na-K-Cl cotransporter and decreases edema formation in permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab 2006, 26:1234-1249.
243. Yang T, Roder KE, Bhat GJ, Thekkumkara TJ, Abbruscato TJ. Protein kinase C family members as a target for regulation of blood-brain barrier Na, K, 2Cl-cotransporter during in vitro stroke conditions and nicotine exposure. Pharm Res 2006, 23:291-302. 10.1007/s11095-005-9143-2, 16450214.
244. Millar ID, Brown PD. NBCe2 exhibits a 3 HCO3-:1 Na+ stoichiometry in mouse choroid plexus epithelial cells. Biochem Biophys Res Commun 2008, 373:550-554. 10.1016/j.bbrc.2008.06.053, 18588858.
245. Taylor CJ, Nicola PA, Wang S, Barrand MA, Hladky SB. Transporters involved in regulation of intracellular pH in primary cultured rat brain endothelial cells. J Physiol 2006, 576:769-785. 10.1113/jphysiol.2006.117374, 1890423, 16916905.
246. Vigne P, Farre AL, Frelin C. Na+-K+-Cl- cotransporter of brain capillary endothelial cells. J Biol Chem 1994, 269:19925-19930.
247. Nicola PA, Taylor CJ, Wang S, Barrand MA, Hladky SB. Transport activities involved in intracellular pH recovery following acid and alkali challenges in rat brain microvascular endothelial cells. Pflugers Arch 2008, 456:801-812. 10.1007/s00424-007-0441-x, 18214525.
248. Johanson CE, Duncan JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD. Multiplicity of cerebrospinal fluid functions: New challenges in health and disease. Cerebrospinal Fluid Res 2008, 5:10. 10.1186/1743-8454-5-10, 2412840, 18479516.
249. Pollay M, Curl F. Secretion of cerebrospinal fluid by the ventricular ependyma of the rabbit. Am J Physiol 1967, 213:1031-1038.
250. Damkier HH, Brown PD, Praetorius J. Epithelial pathways in choroid plexus electrolyte transport. Physiology (Bethesda) 2010, 25:239-249.
251. Praetorius J, Nejsum LN, Nielsen S. A SCL4A10 gene product maps selectively to the basolateral plasma membrane of choroid plexus epithelial cells. Am J Physiol Cell Physiol 2004, 286:C601-C610. 10.1152/ajpcell.00240.2003, 14592810.
252. Jacobs S, Ruusuvuori E, Sipila ST, Haapanen A, Damkier HH, Kurth I, Hentschke M, Schweizer M, Rudhard Y, Laatikainen LM, Tyynela J, Praetorius J, Voipio J, Hübner CA. Mice with targeted Slc4a10 gene disruption have small brain ventricles and show reduced neuronal excitability. Proc Natl Acad Sci USA 2007, 105:311-316. 10.1073/pnas.0705487105, 2224208, 18165320.
253. Praetorius J, Nielsen S. Distribution of sodium transporters and aquaporin-1 in the human choroid plexus. Am J Physiol Cell Physiol 2006, 291:C59-C67. 10.1152/ajpcell.00433.2005, 16481371.
254. Damkier HH, Prasad V, Hubner CA, Praetorius J. Nhe1 is a luminal Na+/H+ exchanger in mouse choroid plexus and is targeted to the basolateral membrane in Ncbe/Nbcn2-null mice. Am J Physiol Cell Physiol 2009, 296:C1291-C1300. 10.1152/ajpcell.00062.2009, 2692415, 19369449.
255. Keep RF, Xiang J, Betz AL. Potassium cotransport at the rat choroid plexus. Am J Physiol Cell Physiol 1994, 267:C1616-C1622.
256. Hughes AL, Pakhomova A, Brown PD. Regulatory volume increase in epithelial cells isolated from the mouse fourth ventricle choroid plexus involves Na+-H+ exchange but not Na+-K+-2Cl-cotransport. Brain Res 2010, 1323:1-10. 10.1016/j.brainres.2009.12.094, 20144884.
257. Redzic ZB, Isakovic AJ, Misirlic Dencic ST, Popadic D, Segal MB. Uneven distribution of nucleoside transporters and intracellular enzymatic degradation prevent transport of intact [14C] adenosine across the sheep choroid plexus epithelium as a monolayer in primary culture. Cerebrospinal Fluid Res 2006, 3:4. 10.1186/1743-8454-3-4, 1450313, 16571111.